Capricor Therapeutics Inc. Common Stock (CAPR)
Stock · NASDAQ · Health Care
$9.59as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About CAPR
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The comp…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 231
- Website
- capricor.com/
Fundamentals
- 1-day range
- $8.9$10.61
- Market cap
- $243.23M
- P/E (trailing)
- —
- P/E (forward)
- -6.34
- EPS (trailing)
- $-2.31
- Dividend yield
- —
- Beta
- 0.55
- Avg. volume
- 5.83M
- Dividend pay date
- June 5, 2019
How Capricor Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 26, 2025 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Capricor Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CAPRCapricor Therapeutics Inc. Common Stock$9.59▼ 4.67%Market cap $243.23MP/E —$2.96$40.37
- MGNXMacroGenics Inc. Common Stock$4.13▲ 1.23%Market cap $242.81MP/E —$1.29$5.08
- ADAGAdagene Inc. American Depositary Shares$3.68▼ 5.64%Market cap $239.77MP/E —$1.3$4.85
- SLGLSol-Gel Technologies Ltd. Ordinary Shares$69.41▼ 4.35%Market cap $230.38MP/E —$21$97.97
- VRXAVeraxa Biotech AG Ordinary Shares$1.36▼ 5.56%Market cap $258.78MP/E —$1.32$27.36
- ALXOALX Oncology Holdings Inc. Common Stock$2▼ 2.44%Market cap $259.71MP/E —$0.96$2.66
- ELDNEledon Pharmaceuticals Inc. Common Stock$3.19▼ 3.92%Market cap $264.75MP/E —$1.35$4.6
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CAPR Capricor Therapeutics Inc. Common Stock | $243.23M | — | $9.59 | ▼ 4.67% | $2.96$40.37 |
| MGNX MacroGenics Inc. Common Stock | $242.81M | — | $4.13 | ▲ 1.23% | $1.29$5.08 |
| ADAG Adagene Inc. American Depositary Shares | $239.77M | — | $3.68 | ▼ 5.64% | $1.3$4.85 |
| SLGL Sol-Gel Technologies Ltd. Ordinary Shares | $230.38M | — | $69.41 | ▼ 4.35% | $21$97.97 |
| VRXA Veraxa Biotech AG Ordinary Shares | $258.78M | — | $1.36 | ▼ 5.56% | $1.32$27.36 |
| ALXO ALX Oncology Holdings Inc. Common Stock | $259.71M | — | $2 | ▼ 2.44% | $0.96$2.66 |
| ELDN Eledon Pharmaceuticals Inc. Common Stock | $264.75M | — | $3.19 | ▼ 3.92% | $1.35$4.6 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Capricor Therapeutics (CAPR) Is Up 62.6% After Mounting Deramiocel FDA Scrutiny And Lawsuits - What's ChangedYahoo · 8/15/2026
- Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.ChartMill · 8/14/2026
- Keep an eye on the top gainers and losers in Friday's session.ChartMill · 8/14/2026
- Friday's session: gap up and gap down stocksChartMill · 8/14/2026
- Capricor: Stock Now Surging On Fresh BLA Updates - What Investors Must KnowSeekingAlpha · 8/14/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 8/14/2026
- Discover the top movers in Friday's pre-market session.ChartMill · 8/14/2026
- CAPR Stock Explodes Premarket: Cantor Flips Bullish, Sees 278% Upside On Deramiocel FDA PathYahoo · 8/14/2026
Insider Activity
Insider Actions →- Bergmann Anthony · June 24, 2026 · Option Exercise400 @ $3.18
- Bergmann Anthony · June 24, 2026 · Sale400 @ $30
- Krasney Karen · June 24, 2026 · Option Exercise400 @ $3.18
- Krasney Karen · June 24, 2026 · Sale400 @ $30
- Bergmann Anthony · June 22, 2026 · Option Exercise500 @ $3.18
- Bergmann Anthony · June 22, 2026 · Sale500 @ $30
- Krasney Karen · June 22, 2026 · Option Exercise500 @ $3.18
- Krasney Karen · June 22, 2026 · Sale500 @ $30
- Maurer Michael T · May 26, 2026 · Grant80.0K
- Bergmann Anthony · May 18, 2026 · Option Exercise3.0K @ $1.39
- Litvack Frank · May 13, 2026 · Option Exercise3.9K @ $1.39
- Bergmann Anthony · May 1, 2026 · Option Exercise25.0K @ $3.18
- Bergmann Anthony · May 1, 2026 · Sale25.0K @ $31.7
- Krasney Karen · May 1, 2026 · Option Exercise25.0K @ $3.18
- Krasney Karen · May 1, 2026 · Sale25.0K @ $31.7
Institutional Ownership
March 31, 2026
- Total shares held
- 37.60M
- Total value held
- $1.14B
- Institutional holders
- 175
- Unknown3.82M
- Unknown3.42M
- Unknown3.40M
- Unknown2.18M
- Unknown2.03M
- Unknown1.51M
- Unknown1.44M
- Unknown1.37M
- Unknown1.12M
- Unknown1.03M
See the full, filterable feed with live charts on the MarketWall dashboard.